Altered plasma membrane dynamics of bone morphogenetic protein receptor type Ia in a low bone mass mouse model

Bone

Volumn 50, Issue 1, 2012, Pages 189-199

  Bragdon, Beth ^a,b   D'Angelo, Alex ^a   Gurski, Lauren ^a   Bonor, Jeremy ^a   Schultz, Kathryn L ^c   Beamer, Wesley G ^c   Rosen, Clifford J ^d   Nohe, Anja ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b UNIVERSITY OF MAINE   (United States)

^c JACKSON LABORATORY   (United States)

^d Maine Medical Center Research Institute   (United States)

Author keywords

Caveolae; Caveolin; Family image correlation spectroscopy; Image cross correlation spectroscopy; Mineralization; Osteoblast

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CAVEOLIN 1; SMAD PROTEIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MARROW CELL; BONE MASS; CAVEOLA; CELL ISOLATION; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPECTROSCOPY; STEM CELL; STROMA CELL;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CALCIFICATION, PHYSIOLOGIC; CAVEOLAE; CAVEOLINS; CELL MEMBRANE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, CONGENIC; MICE, INBRED C3H; MICE, INBRED C57BL; OSTEOPOROSIS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; SMAD PROTEINS; STROMAL CELLS;

EID: 80855130966     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.10.016     Document Type: Article

References (37)

1. Services USDoHaH Bone Health and Osteoporosis: A Report of the Surgeon General 2004, U.S. Department of Health and Human Services, Office of the Surgeon General, Rockville, MD.
2. Ackert-Bicknell C.L., Salisbury J.L., Horowitz M., DeMambro V.E., Horton L.G., Shultz K.L., Lecka-Czernik B., Rosen C.J. A chromosomal inversion within a quantitative trait locus has a major effect on adipogenesis and osteoblastogenesis. Ann N Y Acad Sci 2007, 1116:291-305.
3. Crockett J.C., Rogers M.J., Coxon F.P., Hocking L.J., Helfrich M.H. Bone remodelling at a glance. J Cell Sci 2011, 124:991-998.
4. Liu J.M., Zhao H.Y., Ning G., Chen Y., Zhang L.Z., Sun L.H., Zhao Y.J., Xu M.Y., Chen J.L. IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women. J Bone Miner Metab 2008, 26:159-164.
5. Yakar S., Rosen C.J., Beamer W.G., Ackert-Bicknell C.L., Wu Y., Liu J.L., Ooi G.T., Setser J., Frystyk J., Boisclair Y.R., LeRoith D. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 2002, 110:771-781.
6. Wuster C., Blum W.F., Schlemilch S., Ranke M.B., Ziegler R. Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 1993, 234:249-255.
7. Bouxsein M.L., Rosen C.J., Turner C.H., Ackert C.L., Shultz K.L., Donahue L.R., Churchill G., Adamo M.L., Powell D.R., Turner R.T., Muller R., Beamer W.G. Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo. J Bone Miner Res 2002, 17:570-579.
8. Rosen C.J., Ackert-Bicknell C.L., Adamo M.L., Shultz K.L., Rubin J., Donahue L.R., Horton L.G., Delahunty K.M., Beamer W.G., Sipos J., Clemmons D., Nelson T., Bouxsein M.L., Horowitz M. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 2004, 35:1046-1058.
9. Akeson E.C., Donahue L.R., Beamer W.G., Shultz K.L., Ackert-Bicknell C., Rosen C.J., Corrigan J., Davisson M.T. Chromosomal inversion discovered in C3H/HeJ mice. Genomics 2006, 87:311-313.
10. Moerman E.J., Teng K., Lipschitz D.A., Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004, 3:379-389.
11. Ponce M.L., Koelling S., Kluever A., Heinemann D.E., Miosge N., Wulf G., Frosch K.H., Schutze N., Hufner M., Siggelkow H. Coexpression of osteogenic and adipogenic differentiation markers in selected subpopulations of primary human mesenchymal progenitor cells. J Cell Biochem 2008, 104:1342-1355.
12. Sottile V., Seuwen K. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 2000, 475:201-204.
13. Hata K., Nishimura R., Ikeda F., Yamashita K., Matsubara T., Nokubi T., Yoneda T. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 2003, 14:545-555.
14. Chiellini C., Cochet O., Negroni L., Samson M., Poggi M., Ailhaud G., Alessi M.C., Dani C., Amri E.Z. Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation. BMC Mol Biol 2008, 9:26.
15. Zmuda J.M., Sheu Y.T., Moffett S.P. The search for human osteoporosis genes. J Musculoskelet Neuronal Interact 2006, 6:3-15.
16. Medici M., van Meurs J.B., Rivadeneira F., Zhao H., Arp P.P., Hofman A., Pols H.A., Uitterlinden A.G. BMP-2 gene polymorphisms and osteoporosis: the Rotterdam Study. J Bone Miner Res 2006, 21:845-854.
17. Styrkarsdottir U., Cazier J.B., Kong A., Rolfsson O., Larsen H., Bjarnadottir E., Johannsdottir V.D., Sigurdardottir M.S., Bagger Y., Christiansen C., Reynisdottir I., Grant S.F., Jonasson K., Frigge M.L., Gulcher J.R., Sigurdsson G., Stefansson K. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol 2003, 1:E69.
18. Fujimoto T., Kogo H., Nomura R., Une T. Isoforms of caveolin-1 and caveolar structure. J Cell Sci 2000, 113(Pt 19):3509-3517.
19. Nohe A., Keating E., Knaus P., Petersen N.O. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004, 16:291-299.
20. Thomas C.M., Smart E.J. Caveolae structure and function. J Cell Mol Med 2008, 12:796-809.
21. Bonor J, Adams EL, Bragdon B, Moseychuk O, Czymmek KJ, Nohe A. Initiation of BMP2 Signaling in Domains on the Plasma Membrane. Journal of Cellular Physiology Accepted for publication.
22. Nohe A., Keating E., Underhill T.M., Knaus P., Petersen N.O. Dynamics and interaction of caveolin-1 isoforms with BMP-receptors. J Cell Sci 2005, 118:643-650.
23. Nohe A., Keating E., Underhill T.M., Knaus P., Petersen N.O. Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways. J Cell Sci 2003, 116:3277-3284.
24. Wang A., Ding X., Sheng S., Yao Z. Bone morphogenetic protein receptor in the osteogenic differentiation of rat bone marrow stromal cells. Yonsei Med J 2010, 51:740-745.
25. Brown C.M., Petersen N.O. An image correlation analysis of the distribution of clathrin associated adaptor protein (AP-2) at the plasma membrane. J Cell Sci 1998, 111(Pt 2):271-281.
26. Nohe A., Petersen N.O. Analyzing protein-protein interactions in cell membranes. Bioessays 2004, 26:196-203.
27. Nohe A., Petersen N.O. Analyzing for co-localization of proteins at a cell membrane. Curr Pharm Biotechnol 2004, 5:213-220.
28. Nohe A., Petersen N.O. Image correlation spectroscopy. Sci STKE 2007, 2007:pl7.
29. Jonk L.J., Itoh S., Heldin C.H., ten Dijke P., Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 1998, 273:21145-21152.
30. Bragdon B, Thinakaran S, Moseychuk O, King D, Young K, Litchfield DW, Petersen NO, Nohe A. Casein kinase 2 beta-subunit is a regulator of bone morphogenetic protein 2 signaling. Biophys J 2010;99:897-904.
31. Bragdon B., Thinakaran S., Bonor J., Underhill T.M., Petersen N.O., Nohe A. FRET reveals novel protein-receptor interaction of bone morphogenetic proteins receptors and adaptor protein 2 at the cell surface. Biophys J 2009, 97:1428-1435.
32. Nohe A., Keating E., Loh C., Underhill M.T., Petersen N.O. Caveolin-1 isoform reorganization studied by image correlation spectroscopy. Faraday Discuss 2004, 126:185-195. discussion 245-54.
33. Crockett J.C., Rogers M.J., Coxon F.P., Hocking L.J., Helfrich M.H. Bone remodelling at a glance. J Cell Sci 2011, 124:991-998.
34. Zhang Y.W., Yasui N., Ito K., Huang G., Fujii M., Hanai J., Nogami H., Ochi T., Miyazono K., Ito Y. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A 2000, 97:10549-10554.
35. Lou J., Tu Y., Li S., Manske P.R. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun 2000, 268:757-762.
36. Canalis E., Economides A.N., Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 2003, 24:218-235.
37. Jiang Y., Nohe A., Bragdon B., Tian C., Rudarakanchana N., Morrell N.W., Petersen N.O. Trapping of BMP receptors in distinct membrane domains inhibits their function in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2011.